Valproic acid Terminated Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01010854Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer